TOP STORIES

• COMMENTARY Industry’s Ability to Communicate Being Put to Test as Views on Off-Year Price Cuts Change
  June 11, 2024

• BUSINESS Susana Murteira Tapped as Amgen Japan President
  June 11, 2024

• REGULATORY Japan Eyes Withdrawal Rule for Conditional Approval, More Flexible Nods
  June 10, 2024

• REGULATORY LDP Policy Board Endorses Fiscal Consolidation HQ’s Proposal to Extend CEAs
  June 10, 2024

• COMMENTARY With Only 5 Months Until Nitrosamine Self-Inspection Deadline, Many Challenges Remain
  June 7, 2024

• BUSINESS Overseas Sales Ratio of 25 Japan Drug Makers Reaches 67% in FY2023: Tally
  June 6, 2024

• ORGANIZATION 135 Meds Still in Lag/Loss State in Japan, JPMA Task Force Revving Up Fight
  June 5, 2024

• ORGANIZATION JPMA Pushing Industry-Academia Consortia in Non-Competitive Drug Discovery Fields
  June 5, 2024

• REGULATORY Japan Health Ministry Panel Gives Blessing to Novartis’ PNH Drug Iptacopan and More
  June 4, 2024

• REGULATORY Make Single IRB Mandatory in Multi-Center Trials That Use Competitive Funds: Deregulation Panel
  June 4, 2024

• BUSINESS Pfizer’s RSV Vaccine Abrysvo Now Available in Japan
  June 3, 2024

• REGULATORY Nitrosamine Guideline to Be Proposed as New Topic for ICH at Fukuoka Confab
  May 31, 2024

• BUSINESS Moderna Submits RSV Vaccine in Japan
  May 31, 2024

• REGULATORY Japan Selects JN.1 for COVID-19 Vaccine Formula in 2024-2025 Season
  May 30, 2024

• BUSINESS Asahi Kasei to Buy Calliditas, Bag 1st Therapy for IgA Nephropathy
  May 29, 2024

• BUSINESS AbbVie Japan Eyes Sales of 200 Billion Yen in 5 Years, Rinvoq and Skyrizi as Drivers
  May 29, 2024

• BUSINESS Fuji Pharma Charts Its Future as Japan’s Leading Biosimilar Player, Stelara Follow-On as Pace Setter
  May 28, 2024

• BUSINESS Nippon Shinyaku’s DMD Drug Misses Mark in Confirmatory Study
  May 28, 2024

• BUSINESS MSD Chief Urges Further Reform around Spillovers; Japan Sales Up 11% in 2023
  May 27, 2024

• REGULATORY LDP’s Social Security Commission Urges Govt to Revisit Off-Year Drug Price Revisions
  May 24, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• …
• Next ›
• 最終 »